AdaptHealth AHCO Diabetes Health — Cost of product and supplies
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by AdaptHealth in its filing.
Tagged under the XBRL concept us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization.
The official record: AdaptHealth’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about AdaptHealth's diabetes health — cost of product and supplies.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AdaptHealth's diabetes health — cost of product and supplies?
- AdaptHealth (AHCO) reported diabetes health — cost of product and supplies of $106.96M in Q1 2026.
- How has AdaptHealth's diabetes health — cost of product and supplies changed year-over-year?
- AdaptHealth's diabetes health — cost of product and supplies increased by 2.8% year-over-year, from $104.07M to $106.96M.
- What is the long-term trend for AdaptHealth's diabetes health — cost of product and supplies?
- Over 3 years (2022 to 2025), AdaptHealth's diabetes health — cost of product and supplies has grown at a -2.8% compound annual growth rate (CAGR), from $481.55M to $442.44M.
- What does diabetes health — cost of product and supplies mean?
- Includes the direct costs associated with acquiring or manufacturing the diabetes-related medical devices and consumables sold to patients. Monitoring this metric is essential for evaluating the segment's gross margin performance and the impact of supply chain costs on profitability.